Lp 284 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Lp 284 . Real-time updates on events, politics, business and more.

FDA Grants Orphan Drug Designation to LP-284 for High-Grade B-Cell Lymphomas

December 5, 2023

The FDA has granted orphan drug designation to LP-284 for use in the treatment of patients with high-grade B-cell lymphoma harboring MYC and BCL2 rearrangements.

United States Lantern Pharma Inc Lantern Pharma Lp 284 High Gradeb Cell Lymphoma Blood Cancer

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Lp 284 News Today

FDA Grants Orphan Drug Designation to LP-284 for High-Grade B-Cell Lymphomas

Explore More Categories